Nuvalent, Inc. (NUVL)
102.12
+0.88
(+0.87%)
USD |
NASDAQ |
May 22, 16:00
102.07
-0.05
(-0.05%)
After-Hours: 20:00
Nuvalent Total Liabilities (Quarterly) : 156.78M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 295.31M |
| BioMarin Pharmaceutical, Inc. | 2.379B |
| Olema Pharmaceuticals, Inc. | 50.17M |
| Vera Therapeutics, Inc. | 122.04M |
| Tyra Biosciences, Inc. | 24.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.331B |
| Shareholders Equity (Quarterly) | 1.174B |
| Current Ratio | 16.14 |